Allegations of Misrepresentation: Pharmaceutical Company Faces Scrutiny Over Suboxone Film

Case Overview

This case revolves around a pharmaceutical company that developed a medication known as Suboxone, which is utilized to assist individuals grappling with opioid addiction. Allegations have arisen suggesting that the pharmaceutical company fabricated claims regarding the superiority of Suboxone Film compared to its tablet counterpart. The intent behind these claims is believed to be a strategy to obstruct the entry of generic alternatives into the market. To investigate these allegations, an expert in the pharmaceutical sector, particularly regarding opioids and Suboxone, is sought to provide insight into industry publications and analyses that could clarify whether the film formulation indeed offers any advantages over the tablet version.

Questions to the Pharmacy expert and their responses

Please describe your experience in the pharmaceutical industry, as it pertains to opioids and Suboxone.

I am a licensed Pharmacist (PharmD-2004) with 18 years of experience. I am also trained in clinical pharmacology and pharmaceutical sciences (PhD-2009) and I have 12 years of experience as a faculty member. I am an endowed professor and director of a clinical pharmacology research laboratory and a geriatrics pharmacotherapy program. I can offer assistance with strategy and research.

If retained, would you be able to review industry publications and render an opinion on whether Suboxone film is superior to the tablet version of the drug?

I would pull the literature describing the pharmacokinetics of the Suboxone film and tablets, respectively. I am an expert on evaluating how drugs work in people. I would be happy to discuss this case with you further and lend my expertise.

About the expert

This expert has over 15 years of experience in the field of clinical pharmacy. He obtained both his BS in pharmacy and his PharmD from the Florida Agricultural and Mechanical University, before receiving his PhD in clinical pharmaceutical sciences and pharmacogenomics from the University of Florida. Today, he is a licensed registered pharmacist in the states of Arkansas and Florida. Additionally, this expert is an active member of numerous professional organizations, including the American Pharmacists Association, the American College of Clinical Pharmacy, and the American Society for Clinical Pharmacology and Therapeutics. He is also very active in academia, having received several grants for his research on pharmacogenetics in elderly patients. Moreover, he has published numerous peer-reviewed works and has presented on various topics related to pharmacology. This expert previously served as a staff pharmacist at Shands at UF Hospital, as an intermittent pharmacist at the NF/SG VA Health System and the McClellan Memorial VA Health System, and as an assistant professor of pharmaceutical sciences at the University of Arkansas. Currently, he serves as the director of the geriatric pharmacotherapy program, as the director of the clinical pharmacology research laboratory, and as an associate professor & endowed professor of pharmacotherapy and outcomes science at a major university in Virginia.

E-423332

Specialties:

Pharmacy

Pharmaceutical Company Faces Scrutiny Over Suboxone Film